Status:
WITHDRAWN
Patients Empowered With Digital Scripts: ScalaMed
Lead Sponsor:
Holdsworth House Medical Practice
Collaborating Sponsors:
ScalaMed
Conditions:
Technology
Eligibility:
All Genders
18-85 years
Brief Summary
A prospective qualitative and quantitative controlled study, exploring the impact of patient centred digital prescriptions on health, in patients with chronic health conditions.
Detailed Description
ScalaMed is an innovative new consumer centred solution for securing prescriptions through a blockchain solution - a cryptographic distributed database, that can give consumer access to their prescrip...
Eligibility Criteria
Inclusion
- Ages 18-85
- Cognitively able to understand instructions and care for themselves
- Lives in the community (not institutionalised)
- Owner of a smartphone and able to use Apps
- On 3 or more chronic prescription medications
- Informed consent as documented by signature (Appendix Informed Consent Form)
- Has had experience with prescriptions in Australia for at least 1 year
- For the clinicians - any clinician who is using the ScalaMed prescription system in the Holdsworth House
- For pharmacists - who are utilising the ScalaMed system in one of the four clinics
Exclusion
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study due to language problems, psychological disorders, dementia of the participant
- Previous enrolment into the current study
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03479034
Start Date
January 1 2019
End Date
October 1 2019
Last Update
November 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.